- What does SHSKX invest in?
- The fund's core objective is to generate significant capital appreciation over the long term. It allocates a minimum of 80% of its total portfolio to equity investments, primarily common stocks, of companies engaged in the health sciences and related fields. This broad health sciences sector includes enterprises involved in healthcare equipment and supplies, healthcare providers and services, biotechnology, and pharmaceuticals. Demonstrating a focused strategy, the fund will maintain a concentrated position, investing over 25% of its assets, in these health sciences or associated industries. Additionally, it possesses the flexibility to hold shares in companies located outside the United States.
- What is the expense ratio of SHSKX?
- An expense ratio for BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) is not available from our data sources — neither our market-data feed nor the SEC's structured prospectus and annual-report datasets report one for this share class. The fund's prospectus on the issuer's site carries the authoritative fee.
- How big is SHSKX?
- BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) manages $5.72B in total assets. AUM determines bid-ask liquidity and the fund's vulnerability to closure — funds below ~$50M are at higher risk of liquidation.
- Is SHSKX actively managed or an index fund?
- SHSKX's management style is described in the fund's prospectus. See the description on the Summary tab for the published strategy.
- When was SHSKX launched?
- BlackRock Health Sciences Opportunities Portfolio Class K (SHSKX) launched in June 2016 and is managed by BlackRock / iShares.
- How has SHSKX performed?
- SHSKX's total return — price change plus reinvested distributions — is charted at the top of this page. Switch the price chart to Total Return and pick a 1-year, 3-year, 5-year, or 10-year window to read the compound annual growth rate (CAGR) over each horizon.
